Improving the quality of life in Arizona to benefit future generations.
Revalesio Corporation announced today that it has contracted with Predictive Biomarker Sciences (PBS-Bio) to conduct studies related to the use of Revalesio’s novel anti-inflammatory therapeutic in treating cancer.
To jump-start drug development, PBS-Bio’s analysis helps pharmaceutical companies better understand how their drugs work and identifies biomarkers that can help predict which patients will respond to treatment.
A gift from the Flagstaff Medical Center is expected to enhance Northern Arizona University’s ability to prepare health professionals for patient care.
The $82,666 gift will enable NAU to hire a clinial simulation laboratory specialist tasked with enhancing nursing students’ educational experiences using medium- and high-fidelity equipment in simulation laboratory classrooms.
Arizona Governor Jan Brewer announced that the State is providing $10 million in federal stimulus funds to SFAz as part of a portfolio of Strategic Investments designed to position Arizona for economic growth and stability. The funds – $6.5 million for Research and $3.5 million for Education – will be provided through the Governor’s Office of Economic Recovery with funds from the American Recovery and Reinvestment Act.
This financial award reinforces the State’s commitment to supporting SFAz’s proven model as a public/private partnership, which leverages matching funds from industry and other sources to embed high paying jobs in the state. The stimulus funds will be used to support a variety of carefully screened research initiatives, STEM education programs and graduate research fellowships.
New research shows that not just human memories fade. Scientists from Arizona State University and the Norwegian University of Life Sciences examined how aging impacts the ability of honey bees to find their way home.
While bees are typically impressive navigators, able to wend their way home through complex landscapes after visits to flowers far removed from their nests, aging impairs the bees' ability to extinguish the memory of an unsuitable nest site even after the colony has settled in a new home.
The study appears in the open-access journal PLoS ONE, published by the Public Library of Science.
In an industry that faces increasing challenges in delivering new drugs to patients, Predictive Biomarker Sciences (PBS-Bio) today announced three new contracts aimed at bringing new medicines to the marketplace.
PBS-Bio said it is helping more companies develop therapies against a variety of cancers. Most new cancer drugs fail in late-stage studies, and it can take as much as $1 billion and more than a decade to bring the drugs to market.
To jump-start drug development, PBS-Bio’s analysis helps pharmaceutical companies better understand how their drugs work, and identifies biomarkers that can help predict which patients will respond to treatment.
Ventana Medical Systems Inc., which has grown rapidly since its February 2008 acquisition by Roche Group, will grow even more in southern Arizona, officials announced October 13. Roche plans to invest $180 million in capital improvements and add 500 new jobs at Ventana's Oro Valley site.
The University of Arizona will head a new Southwest Climate Science Center established by the U.S. Department of the Interior to address the current and future effects of climate change on the region's natural and cultural resources.
A $3.1 million, five-year grant has been awarded to the UA to initiate the center, one of eight regional centers established or planned in the nation. It is anticipated that the total funding will increase substantially as the Southwest center ramps up in the near future.
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched the first large-scale, multicenter study to investigate the effectiveness of body cooling treatment in infants and children who have had cardiac arrest. The Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) trials total more than $21 million over six years.
Therapeutic hypothermia, or body cooling, has been successfully used in adults after cardiac arrest and in newborn infants after birth asphyxia, or lack of oxygen, to improve survival and outcomes, but it has not been studied in infants or children who have had cardiac arrest.
In the cafeteria, the biggest threat may not be the kid that wants to eat your French fries or what is truly inside a hotdog. A recent study conducted by Dr. Charles Gerba and the University of Arizona in a K-12 school system found that the germiest place at school is the cafeteria table.
Researchers from the University of Arizona swabbed classrooms and common area surfaces at six schools in a K-12 school system to determine the relative numbers of total heterotrophic bacteria and coliform bacteria on frequently touched hard, non-porous surfaces.
Arizona Gov. Jan Brewer announced Friday a $1 million state investment in a northern Arizona business incubator partnership that will further support research-intensive ventures and small business opportunities in the region, ultimately leading to more local high-wage jobs.
Gov. Jan Brewer, left, presents NAU President John Haeger and NAU vice president for Research Laura Huenneke with a ceremonial check for $500,000 in support of the NAU/NACET partnership. NACET also received $500,000 in Recovery Act funds from Brewer.
The Northern Arizona University/Northern Arizona Center for Emerging Technologies partnership was established two years ago to support the creation of successful science- and technology-based companies in northern Arizona. The new funding will be used to advance the center’s existing projects, increase the number of new projects, cultivate spin-off opportunities, provide research opportunities to undergraduates and mentor graduate researchers in start-up business efforts in a true “grow your own” talent initiative.
For information about Bioscience, please contact:
bioscience@flinn.org or (602) 744-6831
